Tamarix
About
Tamarix Pharma is an early-stage biotechnology company focused on developing novel technologies that restore physiological balance in apoptosis-related diseases. Their lead assets, VBIT-4 and VBIT-12, are designed to target a key mitochondrial process known as VDAC1 oligomerization.
Key facts
At-a-glance profile data
- Website
- tamarix-pharma.com
- Headquarters
- San Diego, United States
- Founded
- 2020
- Employees
- 2
- Total funding
- $15M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 18 Jan 2023 | Seed | $15M | Arch Venture Partners |
Add first review
Frequently asked
How much funding has Tamarix raised?
Tamarix has raised a total of $15M in funding. The most recent round on record is Seed.
How many employees does Tamarix have?
Tamarix has approximately 2 people on record.
What is Tamarix's current status?
Tamarix's current operating status is: Inactive.